GSK is seeking a Director of Oncology Early Translational Biomarkers based in the US to lead translational medicine strategy across an expanding oncology portfolio. You will partner with world-class scientists, clinicians and KOLs to drive biomarker strategies from preclinical through Phase 1, integrating multiple modalities and ensuring regulatory readiness.
The role requires a PhD and/or MD with 5+ years in translational medicine, biomarker science, and clinical development, plus experience
#J-18808-Ljbffr
We have an opening for a Director, Early Oncology Translational Biomarkers in Waltham, MA, United States within Bio & Pharmacology & Health.
All applications are reviewed carefully by our team.
The position is based in Waltham, MA, United States.
This opportunity is part of our work in Bio & Pharmacology & Health.
The advertised compensation is 190.000 - 316.000.
We aim to respond to suitable candidates as soon as possible.